Biphasic effects of propranolol on tumour growth in B16F10 melanoma‐bearing mice

BACKGROUND AND PURPOSE: Propranolol is a vasoactive drug that shows antiangiogenic and antitumour activities in melanoma. However, it is unknown whether these activities are dose‐dependent and whether there is a relationship between systemic vascular effects of propranolol and anti‐melanoma activity...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Pharmacol
Main Authors: Maccari, Sonia, Buoncervello, Maria, Rampin, Andrea, Spada, Massimo, Macchia, Daniele, Giordani, Luciana, Stati, Tonino, Bearzi, Claudia, Catalano, Liviana, Rizzi, Roberto, Gabriele, Lucia, Marano, Giuseppe
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Research Papers
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5192956/
https://ncbi.nlm.nih.gov/pubmed/27792834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13662
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki